ID   SNU-1041
AC   CVCL_L085
SY   SNU 1041; SNU1041
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987966
DR   cancercelllines; CVCL_L085
DR   Cell_Model_Passport; SIDM00173
DR   DepMap; ACH-000618
DR   IARC_TP53; 30156
DR   KCLB; 01041
DR   LiGeA; CCLE_264
DR   PharmacoDB; SNU1041_1435_2019
DR   Wikidata; Q54955090
RX   CelloPub=CLPUB00001;
RX   PubMed=26589293;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   HLA typing: A*02:01,02:01; B*15:01,27:05; C*01:02,04:01; DQA1*05:02,05:02; DQB1*05:01,05:01; DRB1*11:01,11:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Homozygous (DepMap=ACH-000618).
CC   Omics: Deep exome analysis.
CC   Omics: Transcriptome analysis by RNAseq.
ST   Source(s): KCLB=01041
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D3S1358: 15
ST   D5S818: 9
ST   D7S820: 8,12
ST   FGA: 24,25
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 22
//
RX   CelloPub=CLPUB00001;
RA   Kim K.H., Chung P.-S., Park H.M., Rhee C.-S., Park J.-G.;
RT   "Establishment and characterization of cell lines derived from
RT   squamous cell carcinoma of the head and neck.";
RL   Korean J. Head Neck Oncol. 12:181-187(1996).
//
RX   PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878;
RA   Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P.,
RA   Loewer M., Sahin U., Castle J.C.;
RT   "TCLP: an online cancer cell line catalogue integrating HLA type,
RT   predicted neo-epitopes, virus and gene expression.";
RL   Genome Med. 7:118.1-118.7(2015).
//
RX   PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103;
RA   Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C.,
RA   McDonald E.R. 3rd, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X.,
RA   Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F.,
RA   Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R.,
RA   Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C.,
RA   Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A.,
RA   Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D.,
RA   Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L.,
RA   Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A.,
RA   Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D.,
RA   Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M.,
RA   Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R.,
RA   Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A.,
RA   Sellers W.R.;
RT   "Next-generation characterization of the Cancer Cell Line
RT   Encyclopedia.";
RL   Nature 569:503-508(2019).
//